Nikrant Page 67 United States 36% Europe 36% Canada 2% Asia 20% Latin America 2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions At a Glance Appliance 6% Building & Construction 3% Wire & Cable 14% Electrical & Electronics 14%Consumer 21% Packaging 5% Industrial 8% Misc. 3% HealthCare 5% Transportation 21% America 6% 2011 Revenue by Industry Segment2011 Revenue by Industry Segment 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 12-16% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales Target Expanding ProfitsExpanding Profits Page 68 Value Proposition • GSEM is a global leader providing complete specialty solutions encompassing innovative technologies and services to enable customer success Transformation Highlights • Dramatic turnaround of the Engineered Materials business through mix improvement and specialty focus Value Proposition and Transformation Highlights improvement and specialty focus • GLS acquisition successfully integrated, having more than doubled earnings in 3 years • PolyOne culture and strategy now engrained worldwide • Expansion into healthcare with dedicated resources > $15B Addressable Market Page 69 • Polymer design, formulation and service expertise • Broad, global technology base and regional centers of excellence • Ten innovation centers around the world Key Differentiators • Ten innovation centers around the world • Specialty brand leadership with PolyOne, GLS, NEU and ECCOH • Ability to leverage global key account team Page 70 From Volume Commodity-driven product portfolio To Value Specialty technology and solutions EM North America Transformation Volume Sales Gross Margin $ Mix Transformation – Executing the Strategy 2006 2011 2006 2011 2006 2011 Page 71 $12 $29 Operating Income ($ in millions) • Provided access to new customers in specialized, high-growth markets such as healthcare and consumer • Strategic partner to many of the world’s best-known companies GLS Integration Success 16.9% 8.2% 2007 2011 2007 2011 Working Capital % of Sales • Complementary global footprint provided additional cross-selling opportunities • Opportunity to expand margins and drive working capital improvement while remaining customer-focused Page 72 $1.3 $27.6 2006 2011 Healthcare Revenue • Investment in dedicated healthcare team to drive penetration and growth • Leverage product portfolio globally & win specialty business Areas of Focus $10.5 $117.9 2006 2011 Consumer Revenue 2006 2011globally & win specialty business in targeted markets • Aggressively commercialize specialty innovation platforms • Utilize our innovation centers to influence OEM design (Revenue in $ millions) Page 73 • Carbon Nanotube Formulations � Applications: Semiconductor equipment, hard drives � Customer benefits: Scrap cost reduction and clean conductivity • Thermally Conductive Solutions Applications: Sockets and bulb holders for LED lighting Key Innovations � Applications: Sockets and bulb holders for LED lighting � Customer benefits: Cost reduction, energy saving, and design flexibility • FDA-Regulated TPEs � Applications: Food packaging seals, intravenous delivery systems, medical stoppers, prefilled syringes � Customer benefits: Clean and safe elastomers for highly regulated applications Page 74 Critical Imperatives and 2015 Goal Critical Imperatives • Commercialize critical new technology platforms • Manage the mix as we continue to drive the transformation • Global translation of commercial successes 2015 Goal • 12 - 16% return on sales Page 75 Page 76

The good news is there have been numerous studies completed on phthalates.

REGULATORY SUPPORT • Drug delivery devices • Pharmaceutical packaging • Medical equipment KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number level, reducing the risk of change • Allows crystallization in semi-crystalline polymers to begin faster and complete earlier REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Healthcare use limitations apply—see below.

No. 0514.02) Revised 09/21/2021 Page 1 of 2 SCOPE OF ACCREDITATION TO ISO/IEC 17025:2017 POLYMER DIAGNOSTICS INC. 33587 Walker Road Avon Lake, OH 44012 Ana De La Ree Phone: 440-930-3271 CHEMICAL Valid To: December 31, 2021 Certificate Number: 0514.02 In recognition of the successful completion of the A2LA evaluation process, accreditation is granted to this laboratory to perform the following rubber and plastics tests: Test Description: Test Method or Standard: Analysis of Volatile Contaminants from Polymers (Chromatography) VDA 277 FTIR (Fourier Transform Infrared) Spectroscopy ASTM E1252 (Except 7.6, 11.2, and 11.4) Flammability Horizontal Burn of Self-Supporting Plastics ASTM D635; UL 94; IEC 60695-11-10 Horizontal Burn of Materials Used in Occupant Compartments of Motor Vehicles ASTM D5132; FMVSS 302 (49 CFR 571.302); ISO 3785 Vertical Burn, 20 mm ASTM D3801; UL 94; IEC 60695-11-10 Vertical Burn, 125 mm ASTM D5048; UL 94; IEC 60695-11-20 Oxygen Index ASTM D2863 FT1 Flame Test UL1581, Clause 1060; UL2556/CSA C22.2 No 2556, Clause 9.3 Cable Flame Test UL1581, Clause 1061 VW1 Flame Test UL1581, Clause 1080; UL2556/CSA C22.2 No 2556, Clause 9.4 FT2/FH Flame Test UL1581, Clause 1100; UL2556/CSA C22.2 No 2556, Clause 9.1 FV-1 Flame Test UL1581, Clause 1060; UL2556/CSA C22.2 No 2556, Clause 9.5 Thin Material Burning Test UL-94 Glow Wire Test IEC 60695 2-10, 2-11, 2-12, 2-13 RVCM in PVC ASTM D4443 (A2LA Cert.

Avient offers complete and flexible solutions to fulfill technical requirements and local standards.

Did the facility complete any pollution prevention activities in the current NPRI reporting year Report Submission and Electronic Certification NPRI ­ Electronic Statement of Certification Specify the language of correspondence English Comments (optional)   I hereby certify that I have exercised due diligence to ensure that the submitted information is true and complete. 

Ordinary administrative expenses of the Audit Committee that are necessary or appropriate in carrying out its duties While the Audit Committee has the responsibilities and powers set forth in this Charter, it is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company’s financial statements and disclosures are complete and accurate and are in accordance with generally accepted accounting principles and applicable rules and regulations. The Audit Committee, after consultation with management, the independent auditor and others as the committee deems appropriate, shall make the final decision to restate previously issued financial statements, if necessary, because of an error in such financial statements as addressed in Accounting Principles Board Opinion No. 20 (APB Opinion No 20) or shall make the decision to disclose or take actions to prevent future reliance on a previously issued audit report or completed interim review related to previously issued financial statements based upon notification or advisement by its independent auditor.

On January 3, 2017, the Company completed the acquisition of SilCoTec, Inc. On January 3, 2017, the Company completed the acquisition of SilCoTec, Inc. On January 3, 2017, the Company completed the acquisition of SilCoTec, Inc.

In 2020, Avient associates completed over 30,000 hours of training through these various delivery methods. Learners in 36 countries completed nearly 20,000 learning experiences using through the on-demand library of courses. Despite this, we are committed to the process and have completed 30% of prioritized risk assessments.

This procedure was completed by placing one 1/2 inch section of rayon gauze at the apex of each bar, and soaking the gauze with the disinfectant to saturate the material.